(Q39429926)

11 September 2017

title

Clinical characteristics of antiphospholipid antibody syndrome in children (English)

1 reference

11 September 2017

1 reference

von Scheven E

1

1 reference

11 September 2017

Athreya BH

2

1 reference

11 September 2017

Rose CD

3

1 reference

11 September 2017

Goldsmith DP

4

1 reference

11 September 2017

Morton L

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

The Journal of Pediatrics

11 September 2017

published in

1 reference

11 September 2017

volume

129

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

339-345

1 reference

Thrombosis in patients with the lupus anticoagulant

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Antiphospholipid antibodies: more than just a disease marker?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Prevalence of anticardiolipin antibodies in juvenile chronic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Anticardiolipin antibodies in pediatric systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Thrombosis in systemic lupus erythematosus: a French collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Lupus anticoagulant in children with thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Deep vein thrombosis in association with a circulating endogenous anticoagulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Cerebral infarct associated with lupus anticoagulant in an adolescent girl: A case report with review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Childhood stroke and lupus anticoagulant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Childhood adrenal insufficiency, chorea, and antiphospholipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970064-1

10.1016/S0022-3476(96)70064-1

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference